Neurocrine Biosciences, Inc.
USD170.00
+1.48 (+0.88%)
CEO
Kyle W. Gano
IPO Date
1996-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$168.83
Prev. Close
$168.52
Day Low
$168.83
Day High
$171.43
52W Low
$122.14
52W High
$171.43
Market Cap
$17.09B
Volume
1.35M
| 40.2 |
| 31 Dec 2023 | FY | 97.9% | 13.2% | 11.2% | 7.7% | 0.19 | 2.45 | 51.6 |
| 31 Dec 2022 | FY | 98.4% | 10.4% | 9.0% | 6.5% | 0.15 | 2.70 | 74.1 |
| 31 Dec 2021 | FY | 98.7% | 7.9% | 6.5% | 4.3% | 0.32 | 3.96 | 89.9 |
| 31 Dec 2020 | FY | 99.0% | 38.9% | 36.2% | 23.5% | 0.37 | 5.45 | 21.9 |
| 31 Dec 2019 | FY | 99.1% | 4.7% | 5.8% | 2.8% | 0.78 | 1.47 | 266.2 |
| 31 Dec 2018 | FY | 98.9% | 4.7% | 4.4% | 2.1% | 0.81 | 8.36 | 322.7 |
| 31 Dec 2017 | FY | 99.2% | -88.2% | -38.3% | -17.4% | 0.99 | 10.20 | -47.9 |
| 31 Dec 2016 | FY | 100.0% | -940.6% | -44.8% | -38.6% | 0.00 | 10.21 | -23.7 |
| 23.0 |
| 30 Sept 2025 | Q3 | 98.2% | 26.4% | 7.0% | 4.9% | 0.30 | 3.38 | 16.7 |
| 30 Jun 2025 | Q2 | 98.4% | 15.6% | 4.0% | 2.8% | 0.16 | 3.20 | 28.9 |
| 31 Mar 2025 | Q1 | 98.4% | 1.4% | 0.3% | 0.2% | 0.18 | 3.13 | 348.9 |
| 31 Dec 2024 | Q4 | 98.5% | 16.4% | 4.0% | 2.8% | 0.18 | 3.40 | 33.1 |
| 30 Sept 2024 | Q3 | 98.7% | 20.9% | 4.8% | 3.7% | 0.09 | 4.37 | 22.4 |
| 30 Jun 2024 | Q2 | 98.4% | 11.0% | 2.6% | 2.0% | 0.10 | 4.19 | 54.3 |
| 31 Mar 2024 | Q1 | 98.5% | 8.4% | 1.8% | 1.2% | 0.21 | 2.52 | 81.3 |
| 31 Dec 2023 | Q4 | 98.4% | 28.7% | 6.6% | 4.5% | 0.19 | 2.45 | 21.9 |